It was suggested that the addition of DNA methyltransferase inhibitors, such as 5-dAzaC, may restore CASP8 expression and sensitize resistant cells to TRAIL-induced apoptosis in some neuroblastoma and medulloblastoma cells [85]. Here, CASP8 is linked to neuroblastoma.